Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Fulcrum Therapeutics (FULC) Preferred Dividend Payments (2019)

Fulcrum Therapeutics (FULC) has disclosed Preferred Dividend Payments for 1 consecutive years, with $796000.0 as the latest value for Q3 2019.

  • Quarterly Preferred Dividend Payments changed N/A to $796000.0 in Q3 2019 from the year-ago period, while the trailing twelve-month figure was $7.1 million through Dec 2019, changed N/A year-over-year, with the annual reading at $7.1 million for FY2019, 8.68% up from the prior year.
  • Preferred Dividend Payments for Q3 2019 was $796000.0 at Fulcrum Therapeutics, down from $3.3 million in the prior quarter.
  • The five-year high for Preferred Dividend Payments was $3.3 million in Q2 2019, with the low at $796000.0 in Q3 2019.